-
Mashup Score: 0The HemOnc Pulse Live | Blood Cancers Today - 6 hour(s) ago
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7Unanswered Questions in MDS at ‘The HemOnc Pulse’ Live 2024 in Chicago | Blood Cancers Today - 11 hour(s) ago
The panel mainly focused on how to define and classify myelodysplastic syndromes and clonal hematopoiesis of indeterminate potential.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5Dr. Osman on Autoimmunity, Female Sex, and KRAS Mutations in CMML | Blood Cancers Today - 14 hour(s) ago
The case study included four patients with CMML who had KRAS mutations and a multitude of autoimmune diseases.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4Myelofibrosis | Blood Cancers Today - 1 day(s) ago
Myelofibrosis (MF) is a rare blood cancer that leads to scarring in the bone marrow, which alters the normal production of blood cells. Get the latest research and news.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2HMAs Are ‘Cornerstone’ in High-risk MDS Treatment Says Jamile Shammo, MD | Blood Cancers Today - 1 day(s) ago
HMAs such as decitabine and cedazuridine (Inqovi) have become the “cornerstone” of treating high-risk patients.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7Blood Cancers Today - 2 day(s) ago
Translating Hematologic Oncology Discoveries into Practice. Blood Cancers Today is a new publication that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings. Blood Cancers Today was developed to reach all professionals in the hematology/oncology universe, covering the latest news and analysis in leukemia, lymphoma, myeloma, myeloproliferative neoplasms, and other hematologic malignancies.
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 10Meeting News | Blood Cancers Today - 2 day(s) ago
The online home of the latest conference coverage and meeting news for hematologic oncologists. View the latest news on Blood Cancers Today.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 3Liso-Cel ‘Favorable’ Safety Profile in Second-line Follicular Lymphoma | Blood Cancers Today - 3 day(s) ago
At a median follow-up of 18.1 months, the ORR and CR rates were both 95.7% following liso-cel treatment.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
Drs. Lonial, Nabhan, and Stewart discussed the plenary session at ASH 2023, the PERSEUS trial, and treating smoldering MM.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 6The HemOnc Pulse Live | Blood Cancers Today - 3 day(s) ago
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
👏 We're only a few days away from #HOPLive24! 🎙️ Whether you're looking forward to the #bispecifics panel with @Rfonsi1, @mrbishop_UC_BMT, & @AaronGoodman33, or the #AML panel with @Daver_Leukemia & @MikkaelSekeres, there's lots in store! 🙌 Learn more: https://t.co/MydFt6GkqD https://t.co/3BeiSNz1vO
-
👏 We're only a few days away from #HOPLive24! 🎙️ Whether you're looking forward to the #bispecifics panel with @Rfonsi1, @mrbishop_UC_BMT, & @AaronGoodman33, or the #AML panel with @Daver_Leukemia & @MikkaelSekeres, there's lots in store! 🙌 Learn more: https://t.co/MydFt6GkqD https://t.co/3BeiSNz1vO